ArticleClinical & translational immunology2023
Changes in immune cell populations following KappaMab, lenalidomide and low-dose dexamethasone treatment in multiple myeloma.
Samuel E Norton et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.